Notice for leniolisib (Ballia Holdings Pty Ltd)
Active ingredients
leniolisib
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Film-coated tablet
Indication
Treatment of activated phosphoinositide 3-kinase delta syndrome (APDS)
Therapeutic area
Immunology